Does ACALABRUTINIB Cause Off label use? 166 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 166 reports of Off label use have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 1.7% of all adverse event reports for ACALABRUTINIB.
166
Reports of Off label use with ACALABRUTINIB
1.7%
of all ACALABRUTINIB reports
22
Deaths
27
Hospitalizations
How Dangerous Is Off label use From ACALABRUTINIB?
Of the 166 reports, 22 (13.3%) resulted in death, 27 (16.3%) required hospitalization, and 7 (4.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ACALABRUTINIB. However, 166 reports have been filed with the FAERS database.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Dyspnoea (259)
Pneumonia (244)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ACALABRUTINIB Alternatives Have Lower Off label use Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC